Ibunal Syrup (Ibuprofen)

Adult dose

For rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, soft tissue injuries, non-articular rheumatic diseases, acute gout, and psoriatic arthritis, the dosage is 200-600mg orally, 3-4 times daily, not to exceed a total of 3200mg per day. For mild to moderate pain and colds, doses should be 200-400mg orally, 3-4 times daily, and adjusted appropriately based on age and symptoms.

Child dose

For juvenile rheumatoid arthritis, administer 30-40mg per kg of body weight divided into 3-4 doses daily. For children, the single dose is administered orally 3-4 times daily, and for those weighing less than 30kg, the daily amount is restricted.

This medication may pose a risk of gastrointestinal bleeding if taken by individuals who regularly consume more than three drinks a day, so it is essential to consult a doctor or pharmacist. Taking this medication can lead to cardiovascular issues and increase the risk of heart disease or stroke; thus, individuals with cardiovascular diseases or risk factors should exercise particular caution. This medication may cause serious side effects like gastrointestinal bleeding or ulcers, so elderly patients or those taking it for extended periods should monitor for abnormal symptoms during treatment. Individuals with gastrointestinal ulcers or bleeding, severe hepatic or renal impairment, severe heart failure, or hypertension should not take this medication. Those allergic to any component of this medication or with a history of asthma should avoid taking it, and pregnant women in late pregnancy should refrain from use due to potential effects on the fetus. This medication should not be taken in doses exceeding the recommended amount, and it is safest not to take it in combination with other non-steroidal anti-inflammatory drugs. Women who are breastfeeding should stop nursing or discontinue the medication, as it may transfer through breast milk and cause side effects in the infant. Individuals with blood disorders, liver or kidney diseases, heart diseases, hypertension, or a history of hypersensitivity, or those with specific autoimmune diseases should consult healthcare professionals before taking this medication. This medication may interact with aspirin, certain blood pressure medications, diuretics, anticoagulants, and some antidepressants; therefore, individuals taking other medications should inform their doctors or pharmacists. If severe allergic reactions, difficulty breathing, severe skin rash, bleeding, abdominal pain, jaundice, or symptoms of kidney or liver dysfunction occur while taking this medication, it should be discontinued immediately, and medical advice should be sought. This medication should be used for the shortest duration and at the lowest effective dose necessary, with regular blood tests and liver and kidney function tests for those on long-term treatment. In cases of overdose, serious symptoms like dizziness, vomiting, and renal failure may develop; hence, the dosage should be adhered to and any unusual symptoms should prompt a visit to medical facilities.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, peeling skin, mucosal pain in the mouth/eyes, asthma attacks, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), severe malaise, sudden and severe headaches, thunderclap headaches, seizures, confusion, vision disturbances, paralysis, significantly reduced urination, and general body malaise.

Mild side effects

• Headache
• dizziness
• drowsiness
• nausea
• vomiting
• abdominal pain
• diarrhea
• indigestion
• loss of appetite
• stomatitis

Drug interactions

Patients receiving high-dose methotrexate as part of their chemotherapy should not take this medication together with other non-steroidal anti-inflammatory drugs. Patients taking low-dose aspirin, ACE inhibitors, lithium, furosemide and thiazide diuretics, low-dose methotrexate, coumarin anticoagulants (such as warfarin), or selective serotonin reuptake inhibitors should consult with their doctor or pharmacist.

When used domestically, this medication should be stored in a container that is not permeable to air at room temperature between 15 to 25 degrees Celsius. For export, it is recommended to store it in a sealed container that blocks light at room temperature between 1 to 30 degrees Celsius. This storage method helps maintain the medication's effectiveness over time.

Appearance

(Domestic) A syrup with an orange flavor, white to light yellow in color (Export) A syrup with an orange flavor, white to pale yellow in color

Package unit

(Domestic): 500mL/bottle (Export): 100mL/bottle